Harvest Fund Management’s Charles River Laboratories CRL Stock Holding History

Harvest Fund Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	1	–	–	﹤0.01%	542
2025 Q4	$0	Hold	1	–	–	﹤0.01%	614
2025 Q3	$0	Sell	1 -481	-100%	-$76.4K	﹤0.01%	645
2025 Q2	$73K	Sell	482 -156	-24%	-$20.8K	﹤0.01%	402
2025 Q1	$96K	Buy	+638	New	+$107K	﹤0.01%	441
2022 Q1	–	Sell	-504	Closed	-$189K	–	748
2021 Q4	$189K	Sell	504 -759	-60%	-$295K	0.03%	253
2021 Q3	$520K	Hold	1,263	–	–	0.12%	59
2021 Q2	$470K	Buy	1,263 +298	+31%	+$99.5K	0.05%	74
2021 Q1	$279K	Hold	965	–	–	0.03%	107
2020 Q4	$241K	Sell	965 -373	-28%	-$88.8K	0.02%	129
2020 Q3	$314K	Buy	1,338 +712	+114%	+$148K	0.03%	112
2020 Q2	$109K	Hold	626	–	–	0.01%	220
2020 Q1	$78K	Buy	626 +549	+713%	+$82.3K	0.01%	242
2019 Q4	$12K	Hold	77	–	–	﹤0.01%	389
2019 Q3	$10K	Sell	77 -582	-88%	-$78K	﹤0.01%	368
2019 Q2	$94K	Hold	659	–	–	0.01%	209
2019 Q1	$96K	Hold	659	–	–	0.02%	198
2018 Q4	$75K	Buy	+659	New	+$82.5K	0.02%	221

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Harvest Fund Management's CRL Position: Q1 2026 in Review

Harvest Fund Management held its Charles River Laboratories (CRL) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Harvest Fund Management first reported a position in CRL in Q4 2018 and has held it in 18 quarters since. The position peaked at $520K in Q3 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Harvest Fund Management held 1 share of Charles River Laboratories worth $0 as of Q1 2026.
Harvest Fund Management left its Charles River Laboratories share count unchanged in Q1 2026.
Charles River Laboratories made up ﹤0.01% of Harvest Fund Management's portfolio in Q1 2026, its #542 holding.
Harvest Fund Management first reported a position in Charles River Laboratories in Q4 2018 and has held it in 18 quarters since.
Harvest Fund Management's Charles River Laboratories position peaked at $520K in Q3 2021.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.